Yafei Wang1, Yue Zhang1, Lingyi Xu1, Yu Sun1, Lei Xiang2, Meiping Ye2, Suiren Wan1, Bing Zhang2, and Bin Zhu2
1The Laboratory for Medical Electronics, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, China, People's Republic of, 2Department of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China, People's Republic of
Synopsis
Classification
or grading of brain tumor alone would not be enough for clinical use,
therefore we designed a comprehensive multi-layer system combining the two
functions together. Firstly, we designed it as a three-layer system according
to clinic workflow. Then, we extracted new features from multi-modality MRI and
patients’ clinical information, which were easily ignored or difficult found by
eyes. And then we implemented SVM and Tumor Model to classify tumor type and
tumor grade. This study proposed a novel multi-layer system for clinic use by
reducing the diagnosis uncertainty.TARGET AUDIENCE
This work could
benefit neurosurgeon and neuroradiologists in need of a support
decision system.
Purpose
The non-invasive classification and grading of
brain tumor would benefit patients a lot, especially those in need of
pathological section to guide the following treatments. There have been many
researches on the classification or grading of brain tumor, but barely no work in
a comprehensive system combine classification and grading together. Therefore, we designed an automatic multi-layer
classification system to simulate the brain tumor diagnosis process according
to clinic workflow: 1).To indentify a brain tumor based on quantitative
MR spectroscopic (MRS) parameters; 2).To diagnose the brain tumor type based
on T1W/T2W MRI, MRS and clinical information; 3).To indicate
the grade of brain tumor based on T1W/T2W MRI and MRS.
Support Vector Machine (SVM)
1 was
used in the Step 1 and 3, and a Tumor Model was established in Step 2. The whole three steps together constituted an automatic multi-layer classification
system.
Methods
Subjects: Please refer to Table 1 for clinical data used in this
research. Data-driven SVM was used in Step 1 and 3,, whereas an algorithm-driven Tumor Model was established in Step 2. Without the need of training data, data
for Step 1 and 3 can all be used in Step 2.
Sequence: Each
subject underwent T1W, T2W and 2D MRS (TR=2000ms, TE=144ms, voxel=10×10mm
2) scan with volumes of interest (VOI) covering lesion,
edema and healthy areas. All scan was underwent respectively at a 3T MRI scanner
(Achieva 3.0T TX, Philips Medical Systems, the Netherlands).
Feature extraction: Pre-processing
and quantification of MRS data was running on LCModel (a software professional in MR spectra processing) before feature extracting. The input
features for each step are given in Table 2. We
designed a MATLAB Toolbox (Fig. 1) to extract
the quantification features of different areas. The color is
displayed according to the concentration of Cho/Cr, where the red regions represent
suspected tumor lesion with high Cho/Cr. The three regions are manually
selected by the color information and with the help of experienced
neuroradiologists.
Classification and grading: 33 and 18 subjects
for Step 1 and 3 were used respectively for SVM, including machine learning,
parameter optimization and dimension reduction. Because of the lack of data, we
focused on glioma grading in Step 3.In Step 2’s Tumor Model, firstly, we collected
a set for each tumor (G for glioma, M for metastasis, O for meningioma and
others) according to the clinical information, as well as a set, P1, for each
subject. Then, compared P1 with G, M or O to calculate whether P1 was a subset
of them. If it was, we can have the first score for each tumor: Score_G1=length(P1)/length(G); Score_M1=length(P1)/length(M); Score_O1=length(P1)/length(O). Secondly, we collected a MRS set for each tumor (MRS_G for
glioma, MRS_M for
metastasis, MRS_O for
meningioma and others) with mean value
2 of
the NAA/Cr, Cho/Cr and Ins/Cr,
and a MRS
set, P2, for each subject. Pearson
Correlation Coefficient(R) was calculated between P2 and each tumor set to get
the second score: Score_G2=R(MRS_G,P2); Score_M2=R(MRS_M,P2); Score_O2=R(MRS_O,P2). Finally, each tumor had a final score: Score_G=Score_G1+Score_G2; Score_M=Score_M1+Score_M2; Score_O=Score_O1+Score_O2. Tumor with the highest score was considered as the
diagnosed type. And thus, a multi-layer classification system is established,
as shown in Fig. 2.
Results
The
classification performance of each step and the whole system are summarized in
Table 3. The system can clearly distinguish tumor and non-tumor patients (e.g.
inflammation, multiple sclerosis and etc.), different
tumor types and grades with an overall accuracy of 90%. The accuracy of each
step is also quite acceptable. Its comprehensive performance can be useful in
clinical work.
Discussion
we designed a
comprehensive multi-layer system for clinic use. Step 1 has an accuracy of
100%, however, it has 28 support vectors (SVs). It may be caused by the
similarities between tumor and non-tumor, or over-fitting during machine
learning. Step 3 has an accuracy of 100% with 12 features and 13 SVs. Principle
Components Analysis may reduce the number of features and SVs to find the
optimal features. The mean value used in Tumor Model should be updated with
increasing dataset. A more complicated model could improve the accuracy and
help to diagnose more tumors. In our future work, different classification
algorithms and data quality control would help improve the overall system
performance.
Conclusion
This study proposed a novel multi-layer classification
and grading system of brain tumor. It takes in many features that were easily
ignored, and has reached an overall accuracy of 90%. It could be a helpful
auxiliary tool for neurosurgeon and
neuroradiologists by reducing diagnosis uncertainty.
Acknowledgements
The authors would like to appreciate Suiren Wan and Yu Sun for giving research instructions on image; Bin Zhu, Bing Zhang, Lei Xiang and Meiping Ye for supporting in data collection, quality control and results interpreting; Yafei Wang for designing the system; Yue Zhang and Lingyi Xu for assisting in statistical analysis and illustrations in this projects.References
1. Yizeng Liang,et al. Support vector machines and their application in chemistry and
biotechnology[M]. 2011
2. Margarida Julià Sapé, Carles Arús. MRS in
Clinical Practice. Application to Brain Tumour MRS[C], IEEE International
Workshop on Imaging Systems and Techniques.2008 Sept. 2:289 - 293